Diabetes Mellitus, Type 2: all 9,589 studies
Page 84 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 DiabeticsCompletedNCT00993304Phase 1
- Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian EthnicityStatus unknownNCT00992797Phase 2
- Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 DiabetesStatus unknownNCT00991055Phase 4
- A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)CompletedNCT00989079Phase 1
- Linking Self-Management and Primary Care for Diabetes 2CompletedNCT00987285Not applicable
- Online Program Assisting Lifestyle Changes (Asterix 1.0 & Obelix 2.0)CompletedNCT00986375Not applicable
- Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes MellitusCompletedNCT00985361Not applicable
- Increasing Vitamin Intake and Physical ActivityCompletedNCT00985179Not applicable
- Acetyl-L-Carnitine in Type 2 DiabetesCompletedNCT00984750Phase 3
- An Investigation Into Bone Micro-architecture in Women With Type 2 DiabetesCompletedNCT00982371
- Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes MellitusCompletedNCT00982358Phase 4
- The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II DiabetesTerminatedNCT00982293Phase 2
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesCompletedNCT00982254Phase 1
- A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DMCompletedNCT00980187Phase 4
- Improvement of a Physically Active LifestyleCompletedNCT00979719Not applicable
- Safety Study of BMS-816336 in Healthy Male SubjectsCompletedNCT00979368Phase 1
- Postprandial Inflammation and Fatty AcidsCompletedNCT00977262Not applicable
- NOX-E36 First-in-Human (FIH) StudyCompletedNCT00976729Phase 1
- A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 DiabetesCompletedNCT00976261Phase 1
- Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control TrialStatus unknownNCT00975533Phase 3
- Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00975065Phase 4
- Effects of Exenatide on Postprandial Hyperlipidemia and InflammationCompletedNCT00974272Phase 4
- Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 DiabetesCompletedNCT00972452Not applicable
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 DiabetesCompletedNCT00971659Phase 1
- Healing Profile of Titanium Dental Implants Placed in Patients With DiabetesCompletedNCT00971516Not applicable
- Glucose Reduction by Early Acarbose Treatment in Basal InsulinCompletedNCT00970528Phase 4
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneTerminatedNCT00970424Phase 3
- Home Monitoring in the Management of Hypertension and Diabetes MellitusStatus unknownNCT00968786Not applicable
- Effect of Sitagliptin on Endothelial Progenitor CellsCompletedNCT00968006Phase 4
- Assessing Inherited Markers of Metabolic Syndrome in the YoungCompletedNCT00966407
- Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsCompletedNCT00965549Phase 4
- Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese PatientsTerminatedNCT00965302Not applicable
- Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 DiabetesCompletedNCT00964587Not applicable
- A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) ExenatideCompletedNCT00964262Phase 1
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study PopulationCompletedNCT00964184Phase 4
- A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusCompletedNCT00963768Phase 1
- A Study of RO5095932 in Patients With Type 2 Diabetes MellitusCompletedNCT00961909Phase 1
- Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00960791Phase 1
- Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in DiabeticsCompletedNCT00960765
- Tactile Massage in Type 2 DiabetesCompletedNCT00960674Phase 3
- Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal ImpairmentTerminatedNCT00958269Phase 3
- Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)CompletedNCT00957957
- Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes PatientsCompletedNCT00957060Phase 4
- Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 DiabetesCompletedNCT00956735Not applicable
- Reduce Obesity and DiabetesStatus unknownNCT00954577
- Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) LipoproteinsCompletedNCT00953498Phase 4
- The Effects of LAF237 on Gastric Function in Type 2 DiabetesCompletedNCT00952991Phase 3
- A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes MellitusCompletedNCT00952445Phase 2
- A Safety Study of ARRY-403 in Patients With Type 2 DiabetesCompletedNCT00952198Phase 1
- Device-guided Breathing Exercises on Blood Pressure in Diabetic PatientsCompletedNCT00951119Phase 3
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 DiabetesCompletedNCT00950677Phase 4
- Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary CareTerminatedNCT00950534Phase 4
- Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 DiabeticsCompletedNCT00950040Not applicable
- Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell FunctionCompletedNCT00949663Phase 1
- Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) TreatmentCompletedNCT00949442Phase 4
- Risk Factors of Incidence of Type 2 Diabetes and Cardiovascular Diseases---Shanghai Baoshan StudyStatus unknownNCT00949416
- Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With NephropathyStatus unknownNCT00949351Phase 4
- Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational StudyCompletedNCT00949286
- Carotid Intima-media Thickness (IMT) and Large-vessel Atherosclerosis by Multidetector Computed Tomography (MDCT)CompletedNCT00949169
- Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 DiabetesCompletedNCT00949091Phase 1
- Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge MatrixCompletedNCT00948584Not applicable
- Treatment Use of Generex Oral-lyn™ in Patients With DiabetesNo longer availableNCT00948493
- Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 DiabetesSuspendedNCT00948324Phase 4
- Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 DiabetesCompletedNCT00948168Phase 4
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminTerminatedNCT00947557Phase 3
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes MellitusTerminatedNCT00946972Phase 1
- Evaluation of Intermediate Care Clinics for DiabetesCompletedNCT00945204Not applicable
- Exercise and Glycemic Control in Type 2 DiabetesCompletedNCT00945165Not applicable
- Safety of Liraglutide in Pediatric Patients With Type 2 DiabetesCompletedNCT00943501Phase 1
- A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)TerminatedNCT00943371Phase 1
- Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial FunctionCompletedNCT00943059Not applicable
- Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 DiabetesCompletedNCT00942318Phase 4
- Development of Self-Regulation in Individuals With Type 2 DiabetesCompletedNCT00941447Not applicable
- Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes PatientsCompletedNCT00941369Phase 4
- Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes MellitusCompletedNCT00941161Phase 4
- Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)CompletedNCT00940797Phase 2
- Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes PatientsCompletedNCT00940472Phase 2/3
- Effect of Sitagliptin on Postprandial Lipoprotein MetabolismTerminatedNCT00939939Phase 4
- A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy VolunteersCompletedNCT00938275Phase 1
- A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.CompletedNCT00938158Phase 1
- A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male SubjectsCompletedNCT00937872Phase 1
- Effects of Peanut and Peanut Butter Consumption on Blood Lipids and Glycemic Control in Adults With Type 2 DiabetesCompletedNCT00937222Not applicable
- Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy SubjectsCompletedNCT00935467Phase 1
- Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot UlcersCompletedNCT00935051Early Phase 1
- Activity and Metformin Intervention in Obese AdolescentsCompletedNCT00934570Phase 4
- Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 DiabetesCompletedNCT00934414Phase 2
- A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal ImpairmentCompletedNCT00933972Phase 1
- A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male VolunteersCompletedNCT00933530Phase 1
- Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male VolunteersCompletedNCT00933062Phase 1
- Effect of Atorvastatin on Vascular Inflammation in Type 2 DiabetesWithdrawnNCT00932048Not applicable
- Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2CompletedNCT00931372Phase 1
- Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic WomenCompletedNCT00931034Not applicable
- Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy SubjectsCompletedNCT00930865Phase 1
- Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic PatientsCompletedNCT00929539Phase 2
- Interleukin-1 Receptor Antagonist and Insulin SensitivityStatus unknownNCT00928876Phase 2
- Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)CompletedNCT00928005Phase 4
- Type 2 Diabetes and Acute Myocardial InfarctionStatus unknownNCT00926133
- of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).CompletedNCT00925717
- Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideCompletedNCT00924573Phase 3
- A Safety PK/PD Study of SLV337 in Patients With Type 2 DiabetesCompletedNCT00924534Phase 2